Fig. 3
From: EXOSC5: a novel biomarker for poor prognosis in lung adenocarcinoma
EXOSC5 is a high-risk factor in LUAD (NTU cohort). A: Univariate and multivariate OS analyses in the NTU cohort. B: Survival comparison between the high- and low-EXOSC5 groups in the NTU cohort. C-D: EXOSC5 mRNA expression across N stages and stage classifications. E: Three- and five-year OS nomogram incorporating the EXOSC5 immunohistochemistry score, differentiation status, size, and stage classification. F-G: Three-year and five-year ROC curves based on the EXOSC5 immunohistochemistry score, size, stage classification, and risk model